Integrating senior medical direction, clinical due diligence, commercialisation sprints, and health economic strategy across advanced healthcare ecosystems. High-fidelity red teaming and clinical due diligence for health technology VCs.
Converting post-seed founder vision into national policy and category dominance.
Uniting medical-commercial strategy to unlock portfolio value for life-science and technology.
Reframing Antimicrobial Resistance (AMR) through a fresh economic lens with vital knowledge spillovers.
Antimicrobial Resistance through a fresh economic lens with vital knowledge spillovers.
Precision fractional medical direction fusing deep clinical expertise and strategic rigor.
Clinical depth | Capital clarity
Clinical depth | Capital clarity
